Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings at transurethral resection and radical cystectomy, pathology) are collectively used to determine disease status and prognosis, and recommend neoadjuvant, definitive and adjuvant treatments. We analyze the predictive power of these measurements in forecasting two key long-term outcomes following radical cystectomy, i.e., cancer recurrence and survival. Information theory and machine learning algorithms are employed to create predictive models using a large prospective, continuously collected, temporally resolved, primary bladder cancer dataset comprised of 3503 patients (1971-2016). Patient recurrence and survival one, three, and five years a...
This paper presents an application of an artificial neural network to determine survival time of pat...
<p><strong>Purpose.</strong> Assessment of predictors of cancer-specific survival (CSS) in patients ...
Muscle-invasive bladder cancer is a life-threatening disease best managed with multimodal therapy. N...
Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings...
Bladder cancer is a common cancer in genitourinary malignancy. For muscle invasive bladder cancer, s...
Background: Non–muscle-invasive bladder cancer (NMIBC) is characterized by frequent recurrence of th...
Abstract Background Identifying the likelihood of life‐threatening recurrence after radical cystecto...
Purpose: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and ...
International audienceBACKGROUND: Predictive tools can be useful for adapting surveillance or includ...
PURPOSE: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and p...
Objective To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) pro...
Bladder cancer has been increasing globally. Urinary cytology is considered a major screening method...
Background: Although the natural history of urothelial carcinoma of the bladder (UCB) from radical c...
Background: Artificial neural network (ANN) has been used in medicine to predict either the treatmen...
Background: Radical cystectomy for urinary bladder cancer is a procedure associated with a high risk...
This paper presents an application of an artificial neural network to determine survival time of pat...
<p><strong>Purpose.</strong> Assessment of predictors of cancer-specific survival (CSS) in patients ...
Muscle-invasive bladder cancer is a life-threatening disease best managed with multimodal therapy. N...
Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings...
Bladder cancer is a common cancer in genitourinary malignancy. For muscle invasive bladder cancer, s...
Background: Non–muscle-invasive bladder cancer (NMIBC) is characterized by frequent recurrence of th...
Abstract Background Identifying the likelihood of life‐threatening recurrence after radical cystecto...
Purpose: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and ...
International audienceBACKGROUND: Predictive tools can be useful for adapting surveillance or includ...
PURPOSE: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and p...
Objective To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) pro...
Bladder cancer has been increasing globally. Urinary cytology is considered a major screening method...
Background: Although the natural history of urothelial carcinoma of the bladder (UCB) from radical c...
Background: Artificial neural network (ANN) has been used in medicine to predict either the treatmen...
Background: Radical cystectomy for urinary bladder cancer is a procedure associated with a high risk...
This paper presents an application of an artificial neural network to determine survival time of pat...
<p><strong>Purpose.</strong> Assessment of predictors of cancer-specific survival (CSS) in patients ...
Muscle-invasive bladder cancer is a life-threatening disease best managed with multimodal therapy. N...